Skip to main content

Weight Loss Protocol Overview

Overview of the Weight Loss Protocol, including how treatment works and how clinicians evaluate eligibility.

Updated this week

This article applies specifically to the Weight Loss treatment plan.

Requirements may differ for other Maximus programs.
โ€‹
The Maximus Weight Loss Protocol uses clinician-guided GLP-1 and GLP-1 + GIP treatments, including semaglutide and tirzepatide, to support sustainable weight loss.

These medications work by influencing appetite and metabolic pathways that help regulate hunger, blood glucose, and energy balance.

The protocol combines medical treatment with ongoing clinical oversight to support steady, long-term progress.

Treatments That May Be Used in This Protocol

This protocol may include:

  • Semaglutide (GLP-1 receptor agonist)

  • Tirzepatide (GLP-1 + GIP receptor agonist)

These medications are selected by your clinician based on your health profile, goals, and response to treatment.

How It Works (High Level)

GLP-1 and GLP-1 + GIP medications act on receptors involved in:

  • appetite regulation

  • blood glucose control

  • energy balance

Many individuals experience:

  • reduced hunger

  • improved portion control

  • more stable energy levels

These changes can support healthier patterns around eating and overall metabolic function.

Clinical research shows meaningful average weight-loss outcomes over time, though individual results vary.

Who Itโ€™s For

The Weight Loss Protocol may be appropriate for individuals who:

  • are looking for support with weight management

  • want a structured, clinician-guided approach

  • are interested in GLP-1 or GLP-1 + GIP medications

  • have goals related to metabolic health, blood glucose, or appetite regulation

Eligibility is determined by your clinician based on your medical history, symptoms, and lab results.

Who It May Not Be For

Some individuals may be better suited to a different approach depending on:

  • medical history

  • current medications

  • specific health conditions

Your clinician evaluates whether this protocol is appropriate and safe for you.

Quality & Sourcing

Maximus sources semaglutide and tirzepatide through established pharmacy partners.

The medications used in this protocol match the active pharmaceutical ingredients used in commercial versions, helping ensure consistency with clinical research.

What to Expect Over Time

Many individuals first notice changes in:

  • appetite

  • how quickly they feel full

Weight-loss progress typically builds gradually and varies from person to person.

Your clinician monitors your response through check-ins and lab evaluations to guide any adjustments.

How Clinical Decisions Are Made

Your clinician considers:

  • health history

  • lab results

  • treatment goals

  • reported symptoms

  • response over time

Adjustments may be made to ensure the protocol remains safe and aligned with your progress.

Monitoring and Follow-Up

Ongoing monitoring is an important part of treatment.

Your clinician may use:

  • follow-up lab testing

  • symptom check-ins

  • progress evaluations

You can message your clinician through your patient portal for non-urgent questions or updates.

Did this answer your question?